BAYER
BAYRYDrugs in Pipeline
446
Phase 3 Programs
238
Upcoming Catalysts
9
Next Catalyst
Dec 2026
Market Overview
Stock performance and key metrics
9 upcoming, 3 past
How BAYRY's past catalysts played out
BAY86-5016, SH P00331F
Contraception
Recombinant Factor VIII (BAY81-8973)
Blood Coagulation Disorders
Exacyl®
Blood Loss After a Total Hip Replacement
BAY3723113
Obstructive Hypertrophic Cardiomyopathy
BAY2927088
Advanced Solid Tumors
EV/DNG (Qlaira, BAY86-5027, SH T00658ID)
Contraception
Trasylol (Aprotinin, BAYA0128)
Blood Loss, Surgical
Visanne (BAY86-5258, SH T00660AA)
Endometriosis
Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)
Multiple Sclerosis, Relapsing-Remitting
Damoctocog alfa pegol (Jivi, BAY94-9027)
Treatment of Bleeding
Drospirenone/Ethinylestradiol/Methyltetrahydrofolate
Neural Tube Defects
Levonorgestrel IUD (LCS, BAY86-5028)
Contraception
Bifonazole cream 1%
Onychomycosis
Valette
Acne Vulgaris
Naproxen sodium 440 mg / DPH 50 mg (BAY98-7111)
Pain, Postoperative
BAY1841788 / darolutamide (ODM-201)
Metastatic Hormone-sensitive Prostate Cancer
Finerenone
Chronic Kidney Disease
Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine
Common Cold
Medroxyprogesterone acetate
Endometrial Hyperplasia
Nifedipine (Adalat, BAYA1040)
Hypertension
Enoxaparin followed by VKA
Venous Thrombosis
YAZ (SH T00186, BAY86-5300)
Contraception
Lanthanum Carbonate (BAY77-1931)
Hyperphosphatemia
Levonorgestrel IUS (LCS, BAY86-5028)
Contraception
LCS12
Contraception
Yasmin (30 µg EE, 3 mg Drospirenone, BAY86-5131)
Healthy
Levitra (Vardenafil, BAY38-9456)
Erectile Dysfunction
Darolutamide (Nubeqa, BAY1841788)
Prostatic Neoplasms
Butenafine HCl 1% (BAY1896425) - Induction Phase
Dermatitis, Photoallergic
Ethinylestradiol/Gestodene (BAY86-5016)
Contraception
Testosterone undecanoate (TU) - NebidoTM
Hypogonadism
Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027)
Primary Dysmenorrhea
EV/DNG (Qlaira, Natazia, BAY86-5027)
Metrorrhagia
Aspirin (Acetylsalicylic acid, BAYE4465)
Moderate Risk of CVD
Radium-223 dichloride (BAY88-8223)
Prostatic Neoplasms
Riociguat (BAY63-2521)
Hypertension, Pulmonary
Yasmin 20
Contraception
Iopromide 370 mg I/mL
Computed Tomography
Ranibizumab
Macular Degeneration
Best supportive care
Gastrointestinal Stromal Tumors
Clotrimazole, vaginal ovule
Clotrimazole
LNG-IUS (BAY 86-5028)
Contraception
Gadoteridol (ProHance)
Diagnostic Imaging
Unfractionated heparin
Deep Vein Thrombosis
Acetylsalicyclic acid (Fast acting Aspirin, BAY1019036)
Drugs, Investigational
Positive Control-Sodium lauryl sulfate (SLS)
Hypersensitivity
Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106)
Hypertension
Ortho Tri Cyclen Lo
Contraception
Nifurtimox (Lampit, BAYA2502)
Chagas Disease
Recombinant Factor VIII (Kovaltry, BAY81-8973)
Haemophilia A
Advil
Pain
Tedizolid (BAY119-2631)
Bacterial Infections
Skyla (Levonorgestrel, BAY86-5028)
Contraception
Finerenone (Kerendia, BAY94-8862)
Chronic Kidney Disease
Avelox (Moxifloxacin, BAY12-8039)
Infectious Diseases
ProHance
Brain Metastases
BAY86-6150
Hemophilia A, Hemophilia B
Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
Macular Edema
Iloprost (Ventavis inhaled, BAYQ6256)
Hypertension, Pulmonary
Gadopentetate dimeglumine (Magnevist, BAY86-6661)
Magnetic Resonance Imaging
STW5 (Iberogast, BAY98-7411)
Irritable Bowel Syndrome
VEGF Trap-Eye (BAY86-5321)
Myopia, Pathological
Zoladex 3.6Mg Implant
Prostate Cancer
Phenylephrine HCl (Sinus Comfort, BAY112476)
Nasal Congestion Due to Allergic Rhinitis
Darolutamide
High-Risk Localized Prostate Cancer
Molidustat (BAY85-3934)
Anemia
Flexible (extended) treatment of EE20/DRSP (YAZ, BAY86-5300)
Contraception
Kogenate (BAY14-2222)
Hemophilia
Angeliq (Drospirenone/17ß-estradiol, BAY86-4891)
Vasomotor Symptoms
EE20/DRSP (BAY86-5300)
Contraception
Vitamin K antagonist (VKA)
Atrial Fibrillation
Phenylephrine Hydrochloride (HCl) Extended Release (ER) Tablets 30 mg
Vasomotor Rhinitis
Levofloxacin + Ceftriaxone
Pneumonia
Prevacid®
Human Experimentation
8 mg aflibercept (BAY 86-5321) (High Dose)
Diabetic Macular Edema
Gestodene/EE Patch (BAY86-5016)
Contraception
SH T04740B
Dysmenorrhea
Naproxen Sodium 440 mg / DPH 25 mg (BAY98-7111)
Pain, Postoperative
Visanne (SH T00660AA , BAY86-5258)
Endometriosis
EV/DNG (Qlaira, BAY86-5027, SH T00658K)
Contraception
Gadoxetic Acid Disodium (Primovist, BAY86-4873)
Known or Suspected Focal Liver Lesions
Menostar (estradiol transdermal delivery system)
Hot Flashes
SH D 593 B (Miranova)
Contraception
Darbepoetin alfa
Anemia
Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321)
Retinal Vein Occlusion
Fosrenol (Lanthanum Carbonate, BAY77-1931)
Hyperphosphatemia
Azelastine hydrochloride (BAYR9258)
Allergic Rhinitis
Levonorgestrel (Kyleena, BAY86-5028)
Contraception
EE20/DRSP/L-5-MTHF (Beyaz, BAY98-7071)
Contraception
Ethinylestradiol/Gestodene (FC Patch Low BAY86-5016)
Contraception
Acarbose
Diabetes Mellitus, Type 2
alemtuzumab
Leukemia
Valette (Dienogest/EE30, BAY86-5038)
Oral Contraceptive
Gadoquatrane (BAY1747846)
Contrast Enhancement in Magnetic Resonance Imaging
Testogel (Testosterone, BAYV001915)
Androgens (Deficiency)
Minisiston (SH D00342A)
Contraception
Laif® 900, BAY98-7108
Moderate Depressive Episodes (Major Depression)
BAY86-5300
Contraception
Ertapenem
Intraabdominal Infections
Naproxen sodium 440 mg/DPH 50 mg (BAY98-7111)
Pain
Gadoterate meglumine
Contrast Enhancement in Magnetic Resonance Imaging
Oxybutynin (Oxytrol, BAY839380)
Overactive Bladder
Sunscreen Test Code: V53-028
Sun Protection
Omeprazole/sodium bicarbonate
Gastric Acid
cefepime
Febrile Neutropenia
Eylea (Aflibercept, BAY86-5321)
Retinopathy of Prematurity (ROP)
Tadalafil
Erectile Dysfunction
Rivaroxaban
Symptomatic Superficial Vein Thrombosis
omeprazole magnesium (20 mg equivalent)
Gastric Acid
Drug: YAZ flex (SH T00186D)
Primary Dysmenorrhea
Finerenone 20 MG Oral Tablet
Type2diabetes
Acarbose (Glucobay, BAYG5421)
Diabetes Mellitus
Darolutamide (BAY1841788, Nubeqa)
Biochemically Recurrent Prostate Cancer
Rivaroxaban (20 mg)
Rheumatic Heart Disease
drospirenone and ethinyl estradiol
Acne Vulgaris
Rivaroxaban, 10 mg
Heart Failure
0.5mg NETA / 1.0mg E2 (Activella)
Postmenopause
Copanlisib (BAY 80-6946)
Lymphoma, Non-Hodgkin
Amikacin Inhalation Solution (BAY41-6551)
Pneumonia, Bacterial
Gynodian® Depot (BAY86-5032)
Hormone Replacement Therapy
Enoxaparin overlapping with and followed by VKA
Pulmonary Embolism
Gemcitabine
Pancreatic Cancer
Cisplatin
Renal Cell Carcinoma
Menostar (Estradiol, BAY86-5435)
Osteopenia
Calcium carbonate
Hyperphosphatemia
Gestodene/EE (FC Patch Low, BAY86-5016)
Contraception
Sorafenib
Ovarian Cancer
DRSP 3 mg/EE 20 µg (13 cycles)
Dysmenorrhea
Moxifloxacin/Metronidazole or Piperacillin/Tazobactam
Abscess, Intra-Abdominal
Carboplatin/Paclitaxel
Melanoma
Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027)
Metrorrhagia
Regorafenib (Stivarga, BAY73-4506)
Colorectal Neoplasms
Deoxycholic acid injection
Moderate or Severe Submental Fullness
Standard ADT (androgen deprivation therapy)
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
EE20/DRSP(YAZ, BAY86-5300)
Premenstrual Dysphoric Disorder ( PMDD)
Losartan
COVID-19 Associated Cardiac Involvement
Acetylsalicylic acid (Aspirin, BAYE4465) & Lidocain
Common Cold
0.5mg DRSP / 0.5mg E2 (BAY86-4891)
Vasomotor Symptoms
Aflibercept (EYLEA, BAY86-5321)
Glaucoma, Neovascular
Acyclovir 50mg buccal/topical tablet, BAYM008894/UI1614773
Recurrent Herpes Labialis
Aficamten
Pediatric
Azelaic Acid Gel 15% (Finacea, BAY39-6251)
Acne Vulgaris
Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)
Neovascular Age-Related Macular Degeneration
Naproxen Sodium ER (BAYH6689)
Pain
Levonorgestrel (BAY98-7196)
Contraception
Gadobutrol
Contrast Enhancement in Magnetic Resonance Imaging
Rivaroxaban 10 mg qd
Atrial Fibrillation
Copanlisib (Aliqopa, BAY80-6946)
Lymphoma,Non-Hodgkin
Acetylsalicylic Acid (Aspirin, BAYE4465)
Common Cold
Acetylsalicylic acid
Aortic Valve Stenosis
Pantoprazole
Prevention & Control
Dienogest (Visanne, BAY86-5258)
Endometriosis
Asundexian (BAY2433334)
Prevention of Ischemic Stroke
emodepside (BAY 44-4400)
Trichuris Trichiura; Infection
colecalciferol
Multiple Sclerosis
Testosterone gel
Erectile Dysfunction
Standard of Care
Venous Thromboembolism
Tedizolid Phosphate (Sivextro, BAY1192631)
Skin Diseases, Infectious
Rivaroxaban 2.5 Mg Oral Tablet
Chronic Kidney Diseases
Low-molecular-weight heparin
Neoplasm
Rivaroxaban 10 MG
Covid19
EE20/Drospirenone (YAZ, BAY86-5300)
Acne Vulgaris
Methylprednisolone and IVIG
Immune Thrombocytopenic Purpura
Vardenafil ODT (STAXYN, BAY38-9456)
Erectile Dysfunction
Colchicine
Coronavirus
Zevalin ([90]Y-ibritumomab tiuxetan, BAY86-5128)
Lymphoma, Non-Hodgkin
Ertapenem intravenous
Infection
Darolutamide 300 mg
Prostatic Cancer, Castration-Resistant
Sevabertinib
Advanced Non-small Cell Lung Cancer, HER2 Mutation
bemdaneprocel
Parkinsons Disease (PD)
Estradiol/DRSP (Angeliq, BAY86-4891)
Vasomotor Symptoms
Riociguat (Adempas, BAY63-2521)
Hypertension, Pulmonary
Ofloxacin
Pelvic Inflammatory Disease
Gadobutrol (Gadovist, BAY86-4875)
Magnetic Resonance Imaging
Etonogestrel contraceptive implant
Contraceptive Usage
Finerenone (BAY94-8862)
Chronic Kidney Disease
Sorafenib (Nexavar, BAY43-9006)
Carcinoma, Renal Cell
aflibercept 8 mg
Polypoidal Choroidal Vasculopathy
Levofloxacin & Metronidazole
Pelvic Inflammatory Disease
D,L-lysine acetylsalicylate (Aspirin, BAY81-8781) 500 mg IV
Acute Coronary Syndrome
uninterrupted vitamin K antagonist (VKA)
Atrial Fibrillation
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide & Rifampicin
Pulmonary Tuberculosis
Yasmin
Contraception
meropenem, moxifloxacin
Severe Sepsis
Nexavar (Sorafenib, BAY43-9006)
Carcinoma, Renal Cell
I-124 evuzamitide
Cardiac Amyloidosis
Ciprofloxacin (Cipro, BAYQ3939)
Pneumonia
EV/DNG (Qlaira, BAY86-5027)
Oral Contraceptive
Gadolinium
Heart Disease, Ischemic
Recombinant Factor VIII (Kogenate FS, BAY14-2222)
Hemophilia A
Interferon beta-1b
HIV Infections
Phenylephrine
Seasonal Allergic Rhinitis
Ciprofloxacin
Infectious Diseases
LNG IUS
Menopause
BAY94-9027
Hemophilia A
Cipro XR (Ciprofloxacin, BAYQ3939)
Urinary Tract Infection
Erlotinib (Tarceva)
Carcinoma, Hepatocellular
Best standard of care (BSoC)
Hormone Refractory Prostate Cancer
Docetaxel 75 mg/m2
Prostate Cancer
Gadobutrol (Gadovist, Gadavist, BAY86-4875)
Coronary Artery Disease
Naproxen sodium and caffeine (BAY2880376)
Postoperative Dental Pain
Ceftriaxone + Metronidazole
Infection, Intra-abdominal
BAY 59-7939
Pulmonary Embolism
Fondaparinux
Superficial Vein Thrombosis
Zegerid
Intragastric Acidity
Sulbactam/Ampicillin
Pneumonia, Aspiration
Radium-223 dichloride (Xofigo, BAY88-8223)
Prostatic Neoplasms
Rivaroxaban (BAY59-7939)
Venous Thromboembolism
rFVIII (BAY81-8973) on demand
Hemophilia A
Levonorgestrel IUS (Mirena, BAY86-5028)
Menorrhagia
Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose
Macular Edema Secondary to Retinal Vein Occlusion
Gadopentetate dimeglumine (Magnevist)
Cardiovascular Abnormalities
Gadopentetate dimeglumine (Magnevist, BAY86-4882)
Peripheral Vascular Disease
Aflibercept (Eylea, BAY 86-5321)
Glaucoma, Neovascular
Acetylsalicylic acid (Fast release Aspirin, BAY1019036)
Drugs, Investigational
Butenafine HCl 1% (BAY1896425)
Hypersensitivity
Ventavis (Iloprost, BAYQ6256)
Hypertension, Pulmonary
Dabigatran
Hematoma
Rivaroxaban (Xarelto, BAY59-7939)
Pulmonary Embolism
Visudyne
Macular Degeneration
Magnevist (SH L 451A)
Brain Neoplasms
Regorafenib (Stivarga, BAY73- 4506)
Colorectal Neoplasms
Ciprofloxacin single dose
Bacterial Infections
Gadobutrol (Gadavist, Gadovist, BAY86-4875)
Vascular Diseases
Naproxen Sodium IR (Aleve, BAYH6689)
Pain, Postoperative
EE20/DRSP(BAY86-5300)
Endometriosis
Acetylsalicyclic acid (Fast release Aspirin, BAY1019036)
Healthy Subjects
Elinzanetant (BAY3427080)
Vasomotor Symptoms Associated With Menopause
Vardenafil (Levitra, BAY38-9456)
Prostatic Hypertrophy, Benign
Regorafenib (BAY73-4506)
Colorectal Neoplasms
YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)
Contraception
Interferon beta-1b (Betaseron, BAY86-5046)
Multiple Sclerosis
EE20/DRSP (YAZ, BAY86-5300)
Oral Contraceptive
Phenylephrine Hydrochloride (HCl) Extended-Release tablets 30 mg
Blood Pressure
Magnevist
Central Nervous System Diseases
Vasovist (BAY86-5283, MS-325)
Peripheral Vascular Diseases
Moxifloxacin (Avelox, BAY12-8039)
Abscess
Rogaratinib (BAY1163877)
Carcinoma, Transitional Cell
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
Malignant Melanoma
Regorafenib (CT)
Colorectal Cancer
Larotrectinib monotherapy
Differentiated Thyroid Cancer
BAY 3670549
Atrial Fibrillation
GM-CSF, sargramostim
Ovarian Cancer
GM-CSF (Sargramostim)
Leukemia
Darbepoetin
Anemia
Naproxen gel
Soft Tissue Injury
Amikacin (BAY41-6551)
Pneumonia
BAY94-8862
Diabetic Nephropathies
RDEA119
Advanced Cancer
Vilaprisan (BAY1002670)
Leiomyoma
Gadobutrol~0.03 mmol/kg BW (Gadavist, Gadovist, BAY86-4875)
Brain Diseases
Taxane (Cytotoxic, BAY59-8862)
Lymphoma, Non-Hodgkin
Naproxen sodium/Caffeine (BAY2880376)
Pain, Postoperative
Molidustat (BAY 85-3934)
Anemia
Drospirenone/17ß-estradiol (Angeliq, BAY86-4891)
Postmenopause
BAY2927088_formulation A
Advanced Non-small Cell Lung Cancer
BAY3427080
Post-menopausal Vasomotor Symptoms
SH T04769G
Oral Contraceptive
Sagopilone (ZK 219477) + prednisone
Prostate Cancer
Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin
Carcinoma, Hepatocellular
BAY86-9766 MEK Inhibitor + Sorafenib
Carcinoma, Hepatocellular
BAY86-9766+Gemcitabine
Pancreatic Neoplasms
BAY1902607
Cough
STW5 (Iberogast®, BAY98-7411)
Functional Gastrointestinal Disorders
BAY1067197 (10 mg)
Heart Failure
Zabedosertib (BAY1834845)
Atopic Dermatitis
Piroxicam ( BAYl1902)
Contraception, Postcoital
ZK245186
Atopic Dermatitis
Sorafenib (Nexavar, BAY43-9006) + mFOLFOX6 (5-FU, levo-leucovorin, oxaliplatin)
Metastatic Colorectal Cancer
Nifurtimox
Neuroblastoma
Pneumococcal Vaccine
Leukemia
BAY3018250
Thrombolysis
BAY2433334
Atrial Fibrillation (AF)
VVD-133214
Colorectal Adenocarcinoma
Histone Deacetylase Inhibitor, MS-275 (BAY 86-5274, ZK 244894)
Melanoma
Fulacimstat (BAY1142524)
Myocardial Infarction
BAY1193397
Diabetic Foot
BAY2586116 (A1)
Sleep Apnea, Obstructive
Levonorgestrel IUS (BAY86-5028, G04209B)
Contraception
BAY59-8862 (Cytotoxic Taxane)
Carcinoma, Non-Small-Cell Lung
Dehydroepiandrosterone, BAY86-5314
Libido
BAY1213790 (Osocimab)
End-stage Renal Disease
Dexpanthenol foam spray, old formulation
Erythema
BAY2253651
Sleep Apnea, Obstructive
Hydrocortison cream
Atopic Dermatitis
BAY60-4552 plus Vardenafil
Erectile Dysfunction
Mapracorat
Atopic Dermatitis
Darolutamide(BAY1841788, Nubeqa)
Biochemically Recurrent Prostate Cancer
Vardenafil HCl (Levitra, BAY38-9456)
Overactive Bladder
Ethinylestradiol/Gestogene (BAY86-5016)
Contraception
Sagopilone (ZK 219477) + carboplatin
Ovarian Neoplasms
BAY73-4506 (Regorafenib, Stivarga)
Solid Cancer
BAY1817080
Overactive Bladder
EV/DNG (SH T00658L)
Ovulation Inhibition
BAY2757556 (Larotrectinib, Vitrakvi)
Solid Tumors Harboring NTRK Fusion
Vericiguat (BAY1021189) (1.25 mg)
Heart Failure
BAY73-4506
Carcinoma, Hepatocellular
ZK 245186
Atopic Dermatitis
Active comparator
Venous Thrombosis
Refametinib (BAY86-9766)
Carcinoma, Hepatocellular
BAY1142524
Heart Failure
Radium-223 chloride (BAY88-8223)
Breast Cancer
Interferon
Carcinoma, Renal Cell
Sagopilone 16 mg/m^2 i.v., Acetyl-L-Carnitine (ALC) 1000 mg tid, HRPC only: Prednisone or Prednisolone 5 mg bid
Prostate Cancer
Dexpanthenol foam spray, new formulation
Skin Abnormalities
PEG 3350 laxative plus electrolytes (PEG + E)/Macrogol (Movicol®, BAY81-8430)
Constipation
Betaseron (Interferon beta-1b, BAY86-5046)
Multiple Sclerosis
BAY85-3934
Anemia
Zevalin (SH L 749 , BAY86-5128)
Non-Hodgkin's Lymphoma
Cladribine
Acute Biphenotypic Leukemia
Enoxaparin/Vitamin K-Antagonist
Venous Thrombosis
BAY86-4891 (Estradiol / Drospirenone)
Contraception
Runcaciguat (BAY1101042)
Diabetic Retinopathy
Yasminelle (SH T 00186 D)
Contraceptives, Oral
Gadobutrol (Gadavist,Gadovist, BAY86-4875)
Myocardial Perfusion Imaging
BAY 1753011
Heart Failure (HF)
BAY2586116
Sleep Apnea, Obstructive
Sagopilone (BAY86-5302, ZK 219477)
Breast Neoplasms
Combination drug
Cancer
BAY85-8501
Bronchiectasis
Eplerenone
Heart Failure
BAY3283142
Chronic Kidney Disease
Larotrectinib (Vitrakvi, BAY2757556)
Solid Tumors Harboring NTRK Fusion
Sorafenib (BAY43-9006)
Carcinoma, Hepatocellular
Magnevist (Gadopentetate dimeglumine, BAY86-4882)
Myocardial Infarction
Gadobutrol (Gadovist/Gadavist)
Central Nervous System Pathology
Interferon beta 1b (Betaseron, BAY86-5046)
Multiple Sclerosis, Relapsing-Remitting
Capadenoson (BAY68-4986)
Atrial Fibrillation
Xarelto (Rivaroxaban, BAY59-7939)
Atrial Fibrillation
CCR1-Antagonist (BAY86-5047, ZK811752)
Endometriosis
Afatinib
Non-small Cell Lung Carcinoma
Sorafenib (Nexavar,BAY43-9006)
Thyroid Carcinoma
BAY98-7443
Contraception
Fesomersen sodium (BAY2976217)
End Stage Renal Disease Requiring Hemodialysis
Sorafenib (Nexavar, BAY43-9006) + Dacarbazine (DTIC)
Melanoma
Nivolumab (Opdivo)
Colorectal Cancer
lloprost(Ventavis,BAYQ6252, 20 µg/mL)
Pulmonary Arterial Hypertension
Inspra (eplerenone)
Heart Failure
BAY 77-1931
Hyperphosphatemia
Anetumab ravtansine (BAY94-9343)
Mesothelioma
BAY1067197 (treatment 2)
Heart Failure
BAY2395840
Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Levonorgestrel
Endometriosis
Copanlisib (BAY80-6946)
Lymphoma Non-Hodgkin
Bay 59-8862
Carcinoma, Renal Cell
BAY2599023 (DTX201)
Hemophilia A
runcaciguat
Chronic Kidney Disease
E2/DRSP (BAY 86-4891) dose 1 (SH T04984E)
Contraceptive, Oral, Hormonal
Repinotan HCl (BAYX3702)
Stroke
Neladenoson bialanate (BAY1067197)
Heart Failure
SH T00268C
Non Small Cell Lung Cancer
Polyethylene Glycol (PEG 3350)
Constipation
Finerenone (BAY94-8862 ) 10 mg
Type 2 Diabetes Mellitus
Bifonazole spray once daily
Tinea Pedis
Elinzanetant
Sleep Disturbances Associated With Menopause
Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A)
Magnetic Resonance Angiography
AAV2-GDNF gene therapy
Parkinson Disease
OpCT-001
Primary Photoreceptor Disease
Naproxen Sodium (Aleve, BAY117031)
Osteoarthritis, Knee
BAY 3713372
MTAP-deleted Solid Tumors
(LMW) Heparin + Vitamin K Antagonist
Venous Thromboembolism
Rivaroxaban, (BAY59-7939)
Venous Thromboembolism
Sorafenib (BAY 43-9006)
Malignant Melanoma
Interleukin-2 SA
HIV Infections
Candesartan cilexetil (Atacand), 4 mg
Hypertension, Essential
BAY 3401016
Alport Syndrome
anetumab ravtansine
Pancreatic Cancer
Vericiguat (BAY1021189) 2.5 mg, 5 mg or 10 mg IR tablets
Chronic Heart Failure With Preserved Ejection Fraction
Epoetin alfa/beta
Anemia
Asoprisnil (BAY86-5294)
Menorrhagia
Vericiguat (BAY1021189)
Calcific Aortic Valve Disease
BAY1002670
Leiomyoma
Lonaprisan (ZK 230211, BAY86-5044)
Metastatic Breast Cancer
Sagopilone (BAY86-5302 , ZK219477)
Ovarian Neoplasms
Vericiguat (BAY1021189) (5 mg)
Heart Failure
Phenylephrine HCl
Rhinitis
Oxymetazoline HCl 0.05% nasal gel
Nasal Congestion
Regorafenib, (Stivarga, BAY73-4506)
Solid Tumors
Sagopilone (ZK 219477)
Breast Neoplasm
Nifedipine (Adalat CR, BAYA1040) 80mg OD
Hypertension
UFH
Cardiovascular Disease
Vericiguat (BAY1021189) 5 mg
Chronic Heart Failure With Reduced Ejection Fraction
BAY 86-5310 (ZK 283197)
Vasomotor System
Copanlisib
Marginal Zone Lymphoma
Radium-223
Prostate Cancer
sorafenib tosylate
Adult Primary Hepatocellular Carcinoma
Riociguat (Adempas, BAY63-2521).
Hypertension, Pulmonary
chemotherapy followed by Zevalin
Diffuse Large B-cell Lymphoma
Vericiguat Oral Tablet
Post-COVID ME/CFS
Nexavar (Sorafenib)
Breast Cancer
Adempas
Chronic Thromboembolic Disease (CTED)
Sorafenib and Gemcitabine
Carcinoma, Hepatocellular
Rivaroxaban 10 MG Oral Tablet [Xarelto]
Bariatric Surgery
Darolutamide 600 mg twice daily
Prostate Cancer
SH D01155E
Pregnancy, Unplanned
Abiraterone acetate
Prostate Cancer
Etoposide
Lymphoma
Riociguat
Scleroderma
Regorafenib (BAY 73-4506)
Colorectal Cancer Metastatic
Technetium Tc 99M Medronate
Castration-Resistant Prostate Carcinoma
Capecitabine/Cisplatin + Sorafenib
Malignant Neoplasm of Stomach
Interferon-α-2b
Leukemia
CHOP regimen alternate with ESHAP regimen
Peripheral T-cell Lymphoma
Campath-1H
Lymphoplasmacytic Lymphoma
Epirubicin Hydrochloride
Pleomorphic Rhabdomyosarcoma
Concurrent use of Radium Ra 223 dichloride and Abiraterone Acetate plus Prednisone
Prostate Cancer
Non-active base from azelaic acid 15% gel
Perioral Dermatitis
emodepside
Onchocerciasis
Ciprofloxacin (Cipro Inhale, BAYQ3939)
Cystic Fibrosis
Sargramostim (GM-CSF)
Lymphoma
sorafenib, vorinostat and bortezomib
Acute Myeloid Leukemia
CS1001
Advanced Refractory Solid Tumors
ZK-EPO
Melanoma
Spironolactone
Heart Failure
Sorafenib Plus Capecitabine (SorCape)
Colorectal Cancer Metastatic
Ra-223 Dichloride
Sarcoma
Ara-C
AML
Sargramostim
Chronic Lymphocytic Leukemia
Peri-operative darolutamide + surgery.
Prostate Cancer
BAY1213790
Knee Arthroplasty, Total
Isoniazid
Tuberculosis
FOLFOX chemotherapy with oxaliplatin
Esophagogastric Cancer
Radium Ra 223 Dichloride
Prostate Cancer Metastatic to Bone
Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF
AML
Sorafenib, administered orally
Esophageal Cancer
Finerenone Oral Tablet
Kidney Transplant; Complications
Azacytidine
Leukemia
CAMPTH-1H
Non-Hodgkins Lymphoma
CapeOX
Gastric Adenocarcinoma
ISIS 416858
End-stage Renal Disease (ESRD)
Moxifloxacin (with rifampin, pyrazinamide, and ethambutol)
Tuberculosis
Ibritumomab Tiuxetan (Zevalin)
Diffuse Large B-Cell Lymphoma
Vericiguat
Vasospastic Angina
testosterone undecanoate
Nonalcoholic Steatohepatitis
Association of darolutamide and EBRT
Prostate Cancer
Sorafenib and Temozolomide
Recurrent Glioblastoma Multiforme
Azelaic acid foam 15%
Papulopustular Rosacea
Radium-223 dichloride
Prostate Cancer
Hormone Therapy
Breast Cancer
Perindopril
Metastatic Colorectal Cancer
Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection
Multiple Sclerosis, Relapsing-Remitting
ZBEAM (Zevalin, BCNU, Etoposide, Aracytine, Melphalan)
Lymphoma, Large Cell, Diffuse
90Y Ibritumomab tiuxetan
Follicular Lymphoma
Testosterone cypionate
Metastatic Castration-resistant Prostate Cancer
mycophenolate or cyclosporine and methotrexate
Graft Versus Host Disease
R-CHOP Chemotherapy
Diffuse Large B Cell Lymphoma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
BAY86-5016, SH P00331F | Phase 3 | Contraception | - | - |
Recombinant Factor VIII (BAY81-8973) | Phase 3 | Blood Coagulation Disorders | - | - |
Exacyl® | Phase 3 | Blood Loss After a Total Hip Replacement | - | - |
BAY3723113 | Phase 3 | Obstructive Hypertrophic Cardiomyopathy | - | - |
BAY2927088 | Phase 3 | Advanced Solid Tumors | - | - |
EV/DNG (Qlaira, BAY86-5027, SH T00658ID) | Phase 3 | Contraception | - | - |
Trasylol (Aprotinin, BAYA0128) | Phase 3 | Blood Loss, Surgical | - | - |
Visanne (BAY86-5258, SH T00660AA) | Phase 3 | Endometriosis | - | - |
Interferon beta-1b (Betaferon/Betaseron, BAY86-5046) | Phase 3 | Multiple Sclerosis, Relapsing-Remitting | - | - |
Damoctocog alfa pegol (Jivi, BAY94-9027) | Phase 3 | Treatment of Bleeding | - | - |
Drospirenone/Ethinylestradiol/Methyltetrahydrofolate | Phase 3 | Neural Tube Defects | - | - |
Levonorgestrel IUD (LCS, BAY86-5028) | Phase 3 | Contraception | - | - |
Bifonazole cream 1% | Phase 3 | Onychomycosis | - | - |
Valette | Phase 3 | Acne Vulgaris | - | - |
Naproxen sodium 440 mg / DPH 50 mg (BAY98-7111) | Phase 3 | Pain, Postoperative | - | - |
BAY1841788 / darolutamide (ODM-201) | Phase 3 | Metastatic Hormone-sensitive Prostate Cancer | - | - |
Finerenone | Phase 3 | Chronic Kidney Disease | - | - |
Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine | Phase 3 | Common Cold | - | - |
Medroxyprogesterone acetate | Phase 3 | Endometrial Hyperplasia | - | - |
Nifedipine (Adalat, BAYA1040) | Phase 3 | Hypertension | - | - |
Enoxaparin followed by VKA | Phase 3 | Venous Thrombosis | - | - |
YAZ (SH T00186, BAY86-5300) | Phase 3 | Contraception | - | - |
Lanthanum Carbonate (BAY77-1931) | Phase 3 | Hyperphosphatemia | - | - |
Levonorgestrel IUS (LCS, BAY86-5028) | Phase 3 | Contraception | - | - |
LCS12 | Phase 3 | Contraception | - | - |
Yasmin (30 µg EE, 3 mg Drospirenone, BAY86-5131) | Phase 3 | Healthy | - | - |
Levitra (Vardenafil, BAY38-9456) | Phase 3 | Erectile Dysfunction | - | - |
Darolutamide (Nubeqa, BAY1841788) | Phase 3 | Prostatic Neoplasms | - | - |
Butenafine HCl 1% (BAY1896425) - Induction Phase | Phase 3 | Dermatitis, Photoallergic | - | - |
Ethinylestradiol/Gestodene (BAY86-5016) | Phase 3 | Contraception | - | - |
Testosterone undecanoate (TU) - NebidoTM | Phase 3 | Hypogonadism | - | - |
Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027) | Phase 3 | Primary Dysmenorrhea | - | - |
EV/DNG (Qlaira, Natazia, BAY86-5027) | Phase 3 | Metrorrhagia | - | - |
Aspirin (Acetylsalicylic acid, BAYE4465) | Phase 3 | Moderate Risk of CVD | - | - |
Radium-223 dichloride (BAY88-8223) | Phase 3 | Prostatic Neoplasms | - | - |
Riociguat (BAY63-2521) | Phase 3 | Hypertension, Pulmonary | - | - |
Yasmin 20 | Phase 3 | Contraception | - | - |
Iopromide 370 mg I/mL | Phase 3 | Computed Tomography | - | - |
Ranibizumab | Phase 3 | Macular Degeneration | - | - |
Best supportive care | Phase 3 | Gastrointestinal Stromal Tumors | - | - |
Clotrimazole, vaginal ovule | Phase 3 | Clotrimazole | - | - |
LNG-IUS (BAY 86-5028) | Phase 3 | Contraception | - | - |
Gadoteridol (ProHance) | Phase 3 | Diagnostic Imaging | - | - |
Unfractionated heparin | Phase 3 | Deep Vein Thrombosis | - | - |
Acetylsalicyclic acid (Fast acting Aspirin, BAY1019036) | Phase 3 | Drugs, Investigational | - | - |
Positive Control-Sodium lauryl sulfate (SLS) | Phase 3 | Hypersensitivity | - | - |
Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106) | Phase 3 | Hypertension | - | - |
Ortho Tri Cyclen Lo | Phase 3 | Contraception | - | - |
Nifurtimox (Lampit, BAYA2502) | Phase 3 | Chagas Disease | - | - |
Recombinant Factor VIII (Kovaltry, BAY81-8973) | Phase 3 | Haemophilia A | - | - |
Advil | Phase 3 | Pain | - | - |
Tedizolid (BAY119-2631) | Phase 3 | Bacterial Infections | - | - |
Skyla (Levonorgestrel, BAY86-5028) | Phase 3 | Contraception | - | - |
Finerenone (Kerendia, BAY94-8862) | Phase 3 | Chronic Kidney Disease | - | - |
Avelox (Moxifloxacin, BAY12-8039) | Phase 3 | Infectious Diseases | - | - |
ProHance | Phase 3 | Brain Metastases | - | - |
BAY86-6150 | Phase 3 | Hemophilia A, Hemophilia B | - | - |
Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321) | Phase 3 | Macular Edema | - | - |
Iloprost (Ventavis inhaled, BAYQ6256) | Phase 3 | Hypertension, Pulmonary | - | - |
Gadopentetate dimeglumine (Magnevist, BAY86-6661) | Phase 3 | Magnetic Resonance Imaging | - | - |
STW5 (Iberogast, BAY98-7411) | Phase 3 | Irritable Bowel Syndrome | - | - |
VEGF Trap-Eye (BAY86-5321) | Phase 3 | Myopia, Pathological | - | - |
Zoladex 3.6Mg Implant | Phase 3 | Prostate Cancer | - | - |
Phenylephrine HCl (Sinus Comfort, BAY112476) | Phase 3 | Nasal Congestion Due to Allergic Rhinitis | - | - |
Darolutamide | Phase 3 | High-Risk Localized Prostate Cancer | - | - |
Molidustat (BAY85-3934) | Phase 3 | Anemia | - | - |
Flexible (extended) treatment of EE20/DRSP (YAZ, BAY86-5300) | Phase 3 | Contraception | - | - |
Kogenate (BAY14-2222) | Phase 3 | Hemophilia | - | - |
Angeliq (Drospirenone/17ß-estradiol, BAY86-4891) | Phase 3 | Vasomotor Symptoms | - | - |
EE20/DRSP (BAY86-5300) | Phase 3 | Contraception | - | - |
Vitamin K antagonist (VKA) | Phase 3 | Atrial Fibrillation | - | - |
Phenylephrine Hydrochloride (HCl) Extended Release (ER) Tablets 30 mg | Phase 3 | Vasomotor Rhinitis | - | - |
Levofloxacin + Ceftriaxone | Phase 3 | Pneumonia | - | - |
Prevacid® | Phase 3 | Human Experimentation | - | - |
8 mg aflibercept (BAY 86-5321) (High Dose) | Phase 3 | Diabetic Macular Edema | - | - |
Gestodene/EE Patch (BAY86-5016) | Phase 3 | Contraception | - | - |
SH T04740B | Phase 3 | Dysmenorrhea | - | - |
Naproxen Sodium 440 mg / DPH 25 mg (BAY98-7111) | Phase 3 | Pain, Postoperative | - | - |
Visanne (SH T00660AA , BAY86-5258) | Phase 3 | Endometriosis | - | - |
EV/DNG (Qlaira, BAY86-5027, SH T00658K) | Phase 3 | Contraception | - | - |
Gadoxetic Acid Disodium (Primovist, BAY86-4873) | Phase 3 | Known or Suspected Focal Liver Lesions | - | - |
Menostar (estradiol transdermal delivery system) | Phase 3 | Hot Flashes | - | - |
SH D 593 B (Miranova) | Phase 3 | Contraception | - | - |
Darbepoetin alfa | Phase 3 | Anemia | - | - |
Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321) | Phase 3 | Retinal Vein Occlusion | - | - |
Fosrenol (Lanthanum Carbonate, BAY77-1931) | Phase 3 | Hyperphosphatemia | - | - |
Azelastine hydrochloride (BAYR9258) | Phase 3 | Allergic Rhinitis | - | - |
Levonorgestrel (Kyleena, BAY86-5028) | Phase 3 | Contraception | - | - |
EE20/DRSP/L-5-MTHF (Beyaz, BAY98-7071) | Phase 3 | Contraception | - | - |
Ethinylestradiol/Gestodene (FC Patch Low BAY86-5016) | Phase 3 | Contraception | - | - |
Acarbose | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
alemtuzumab | Phase 3 | Leukemia | - | - |
Valette (Dienogest/EE30, BAY86-5038) | Phase 3 | Oral Contraceptive | - | - |
Gadoquatrane (BAY1747846) | Phase 3 | Contrast Enhancement in Magnetic Resonance Imaging | - | - |
Testogel (Testosterone, BAYV001915) | Phase 3 | Androgens (Deficiency) | - | - |
Minisiston (SH D00342A) | Phase 3 | Contraception | - | - |
Laif® 900, BAY98-7108 | Phase 3 | Moderate Depressive Episodes (Major Depression) | - | - |
BAY86-5300 | Phase 3 | Contraception | - | - |
Ertapenem | Phase 3 | Intraabdominal Infections | - | - |
Naproxen sodium 440 mg/DPH 50 mg (BAY98-7111) | Phase 3 | Pain | - | - |
Gadoterate meglumine | Phase 3 | Contrast Enhancement in Magnetic Resonance Imaging | - | - |
Oxybutynin (Oxytrol, BAY839380) | Phase 3 | Overactive Bladder | - | - |
Sunscreen Test Code: V53-028 | Phase 3 | Sun Protection | - | - |
Omeprazole/sodium bicarbonate | Phase 3 | Gastric Acid | - | - |
cefepime | Phase 3 | Febrile Neutropenia | - | - |
Eylea (Aflibercept, BAY86-5321) | Phase 3 | Retinopathy of Prematurity (ROP) | - | - |
Tadalafil | Phase 3 | Erectile Dysfunction | - | - |
Rivaroxaban | Phase 3 | Symptomatic Superficial Vein Thrombosis | - | - |
omeprazole magnesium (20 mg equivalent) | Phase 3 | Gastric Acid | - | - |
Drug: YAZ flex (SH T00186D) | Phase 3 | Primary Dysmenorrhea | - | - |
Finerenone 20 MG Oral Tablet | Phase 3 | Type2diabetes | - | - |
Acarbose (Glucobay, BAYG5421) | Phase 3 | Diabetes Mellitus | - | - |
Darolutamide (BAY1841788, Nubeqa) | Phase 3 | Biochemically Recurrent Prostate Cancer | - | - |
Rivaroxaban (20 mg) | Phase 3 | Rheumatic Heart Disease | - | - |
drospirenone and ethinyl estradiol | Phase 3 | Acne Vulgaris | - | - |
Rivaroxaban, 10 mg | Phase 3 | Heart Failure | - | - |
0.5mg NETA / 1.0mg E2 (Activella) | Phase 3 | Postmenopause | - | - |
Copanlisib (BAY 80-6946) | Phase 3 | Lymphoma, Non-Hodgkin | - | - |
Amikacin Inhalation Solution (BAY41-6551) | Phase 3 | Pneumonia, Bacterial | - | - |
Gynodian® Depot (BAY86-5032) | Phase 3 | Hormone Replacement Therapy | - | - |
Enoxaparin overlapping with and followed by VKA | Phase 3 | Pulmonary Embolism | - | - |
Gemcitabine | Phase 3 | Pancreatic Cancer | - | - |
Cisplatin | Phase 3 | Renal Cell Carcinoma | - | - |
Menostar (Estradiol, BAY86-5435) | Phase 3 | Osteopenia | - | - |
Calcium carbonate | Phase 3 | Hyperphosphatemia | - | - |
Gestodene/EE (FC Patch Low, BAY86-5016) | Phase 3 | Contraception | - | - |
Sorafenib | Phase 3 | Ovarian Cancer | - | - |
DRSP 3 mg/EE 20 µg (13 cycles) | Phase 3 | Dysmenorrhea | - | - |
Moxifloxacin/Metronidazole or Piperacillin/Tazobactam | Phase 3 | Abscess, Intra-Abdominal | - | - |
Carboplatin/Paclitaxel | Phase 3 | Melanoma | - | - |
Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027) | Phase 3 | Metrorrhagia | - | - |
Regorafenib (Stivarga, BAY73-4506) | Phase 3 | Colorectal Neoplasms | - | - |
Deoxycholic acid injection | Phase 3 | Moderate or Severe Submental Fullness | - | - |
Standard ADT (androgen deprivation therapy) | Phase 3 | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | - | - |
EE20/DRSP(YAZ, BAY86-5300) | Phase 3 | Premenstrual Dysphoric Disorder ( PMDD) | - | - |
Losartan | Phase 3 | COVID-19 Associated Cardiac Involvement | - | - |
Acetylsalicylic acid (Aspirin, BAYE4465) & Lidocain | Phase 3 | Common Cold | - | - |
0.5mg DRSP / 0.5mg E2 (BAY86-4891) | Phase 3 | Vasomotor Symptoms | - | - |
Aflibercept (EYLEA, BAY86-5321) | Phase 3 | Glaucoma, Neovascular | - | - |
Acyclovir 50mg buccal/topical tablet, BAYM008894/UI1614773 | Phase 3 | Recurrent Herpes Labialis | - | - |
Aficamten | Phase 3 | Pediatric | - | - |
Azelaic Acid Gel 15% (Finacea, BAY39-6251) | Phase 3 | Acne Vulgaris | - | - |
Aflibercept High Dose VEGF Trap-Eye (BAY86-5321) | Phase 3 | Neovascular Age-Related Macular Degeneration | - | - |
Naproxen Sodium ER (BAYH6689) | Phase 3 | Pain | - | - |
Levonorgestrel (BAY98-7196) | Phase 3 | Contraception | - | - |
Gadobutrol | Phase 3 | Contrast Enhancement in Magnetic Resonance Imaging | - | - |
Rivaroxaban 10 mg qd | Phase 3 | Atrial Fibrillation | - | - |
Copanlisib (Aliqopa, BAY80-6946) | Phase 3 | Lymphoma,Non-Hodgkin | - | - |
Acetylsalicylic Acid (Aspirin, BAYE4465) | Phase 3 | Common Cold | - | - |
Acetylsalicylic acid | Phase 3 | Aortic Valve Stenosis | - | - |
Pantoprazole | Phase 3 | Prevention & Control | - | - |
Dienogest (Visanne, BAY86-5258) | Phase 3 | Endometriosis | - | - |
Asundexian (BAY2433334) | Phase 3 | Prevention of Ischemic Stroke | - | - |
emodepside (BAY 44-4400) | Phase 3 | Trichuris Trichiura; Infection | - | - |
colecalciferol | Phase 3 | Multiple Sclerosis | - | - |
Testosterone gel | Phase 3 | Erectile Dysfunction | - | - |
Standard of Care | Phase 3 | Venous Thromboembolism | - | - |
Tedizolid Phosphate (Sivextro, BAY1192631) | Phase 3 | Skin Diseases, Infectious | - | - |
Rivaroxaban 2.5 Mg Oral Tablet | Phase 3 | Chronic Kidney Diseases | - | - |
Low-molecular-weight heparin | Phase 3 | Neoplasm | - | - |
Rivaroxaban 10 MG | Phase 3 | Covid19 | - | - |
EE20/Drospirenone (YAZ, BAY86-5300) | Phase 3 | Acne Vulgaris | - | - |
Methylprednisolone and IVIG | Phase 3 | Immune Thrombocytopenic Purpura | - | - |
Vardenafil ODT (STAXYN, BAY38-9456) | Phase 3 | Erectile Dysfunction | - | - |
Colchicine | Phase 3 | Coronavirus | - | - |
Zevalin ([90]Y-ibritumomab tiuxetan, BAY86-5128) | Phase 3 | Lymphoma, Non-Hodgkin | - | - |
Ertapenem intravenous | Phase 3 | Infection | - | - |
Darolutamide 300 mg | Phase 3 | Prostatic Cancer, Castration-Resistant | - | - |
Sevabertinib | Phase 3 | Advanced Non-small Cell Lung Cancer, HER2 Mutation | - | - |
bemdaneprocel | Phase 3 | Parkinsons Disease (PD) | - | - |
Estradiol/DRSP (Angeliq, BAY86-4891) | Phase 3 | Vasomotor Symptoms | - | - |
Riociguat (Adempas, BAY63-2521) | Phase 3 | Hypertension, Pulmonary | - | - |
Ofloxacin | Phase 3 | Pelvic Inflammatory Disease | - | - |
Gadobutrol (Gadovist, BAY86-4875) | Phase 3 | Magnetic Resonance Imaging | - | - |
Etonogestrel contraceptive implant | Phase 3 | Contraceptive Usage | - | - |
Finerenone (BAY94-8862) | Phase 3 | Chronic Kidney Disease | - | - |
Sorafenib (Nexavar, BAY43-9006) | Phase 3 | Carcinoma, Renal Cell | - | - |
aflibercept 8 mg | Phase 3 | Polypoidal Choroidal Vasculopathy | - | - |
Levofloxacin & Metronidazole | Phase 3 | Pelvic Inflammatory Disease | - | - |
D,L-lysine acetylsalicylate (Aspirin, BAY81-8781) 500 mg IV | Phase 3 | Acute Coronary Syndrome | - | - |
uninterrupted vitamin K antagonist (VKA) | Phase 3 | Atrial Fibrillation | - | - |
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide & Rifampicin | Phase 3 | Pulmonary Tuberculosis | - | - |
Yasmin | Phase 3 | Contraception | - | - |
meropenem, moxifloxacin | Phase 3 | Severe Sepsis | - | - |
Nexavar (Sorafenib, BAY43-9006) | Phase 3 | Carcinoma, Renal Cell | - | - |
I-124 evuzamitide | Phase 3 | Cardiac Amyloidosis | - | - |
Ciprofloxacin (Cipro, BAYQ3939) | Phase 3 | Pneumonia | - | - |
EV/DNG (Qlaira, BAY86-5027) | Phase 3 | Oral Contraceptive | - | - |
Gadolinium | Phase 3 | Heart Disease, Ischemic | - | - |
Recombinant Factor VIII (Kogenate FS, BAY14-2222) | Phase 3 | Hemophilia A | - | - |
Interferon beta-1b | Phase 3 | HIV Infections | - | - |
Phenylephrine | Phase 3 | Seasonal Allergic Rhinitis | - | - |
Ciprofloxacin | Phase 3 | Infectious Diseases | - | - |
LNG IUS | Phase 3 | Menopause | - | - |
BAY94-9027 | Phase 3 | Hemophilia A | - | - |
Cipro XR (Ciprofloxacin, BAYQ3939) | Phase 3 | Urinary Tract Infection | - | - |
Erlotinib (Tarceva) | Phase 3 | Carcinoma, Hepatocellular | - | - |
Best standard of care (BSoC) | Phase 3 | Hormone Refractory Prostate Cancer | - | - |
Docetaxel 75 mg/m2 | Phase 3 | Prostate Cancer | - | - |
Gadobutrol (Gadovist, Gadavist, BAY86-4875) | Phase 3 | Coronary Artery Disease | - | - |
Naproxen sodium and caffeine (BAY2880376) | Phase 3 | Postoperative Dental Pain | - | - |
Ceftriaxone + Metronidazole | Phase 3 | Infection, Intra-abdominal | - | - |
BAY 59-7939 | Phase 3 | Pulmonary Embolism | - | - |
Fondaparinux | Phase 3 | Superficial Vein Thrombosis | - | - |
Zegerid | Phase 3 | Intragastric Acidity | - | - |
Sulbactam/Ampicillin | Phase 3 | Pneumonia, Aspiration | - | - |
Radium-223 dichloride (Xofigo, BAY88-8223) | Phase 3 | Prostatic Neoplasms | - | - |
Rivaroxaban (BAY59-7939) | Phase 3 | Venous Thromboembolism | - | - |
rFVIII (BAY81-8973) on demand | Phase 3 | Hemophilia A | - | - |
Levonorgestrel IUS (Mirena, BAY86-5028) | Phase 3 | Menorrhagia | - | - |
Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose | Phase 3 | Macular Edema Secondary to Retinal Vein Occlusion | - | - |
Gadopentetate dimeglumine (Magnevist) | Phase 3 | Cardiovascular Abnormalities | - | - |
Gadopentetate dimeglumine (Magnevist, BAY86-4882) | Phase 3 | Peripheral Vascular Disease | - | - |
Aflibercept (Eylea, BAY 86-5321) | Phase 3 | Glaucoma, Neovascular | - | - |
Acetylsalicylic acid (Fast release Aspirin, BAY1019036) | Phase 3 | Drugs, Investigational | - | - |
Butenafine HCl 1% (BAY1896425) | Phase 3 | Hypersensitivity | - | - |
Ventavis (Iloprost, BAYQ6256) | Phase 3 | Hypertension, Pulmonary | - | - |
Dabigatran | Phase 3 | Hematoma | - | - |
Rivaroxaban (Xarelto, BAY59-7939) | Phase 3 | Pulmonary Embolism | - | - |
Visudyne | Phase 3 | Macular Degeneration | - | - |
Magnevist (SH L 451A) | Phase 3 | Brain Neoplasms | - | - |
Regorafenib (Stivarga, BAY73- 4506) | Phase 3 | Colorectal Neoplasms | - | - |
Ciprofloxacin single dose | Phase 3 | Bacterial Infections | - | - |
Gadobutrol (Gadavist, Gadovist, BAY86-4875) | Phase 3 | Vascular Diseases | - | - |
Naproxen Sodium IR (Aleve, BAYH6689) | Phase 3 | Pain, Postoperative | - | - |
EE20/DRSP(BAY86-5300) | Phase 3 | Endometriosis | - | - |
Acetylsalicyclic acid (Fast release Aspirin, BAY1019036) | Phase 3 | Healthy Subjects | - | - |
Elinzanetant (BAY3427080) | Phase 3 | Vasomotor Symptoms Associated With Menopause | - | - |
Vardenafil (Levitra, BAY38-9456) | Phase 3 | Prostatic Hypertrophy, Benign | - | - |
Regorafenib (BAY73-4506) | Phase 3 | Colorectal Neoplasms | - | - |
YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300) | Phase 3 | Contraception | - | - |
Interferon beta-1b (Betaseron, BAY86-5046) | Phase 3 | Multiple Sclerosis | - | - |
EE20/DRSP (YAZ, BAY86-5300) | Phase 3 | Oral Contraceptive | - | - |
Phenylephrine Hydrochloride (HCl) Extended-Release tablets 30 mg | Phase 3 | Blood Pressure | - | - |
Magnevist | Phase 3 | Central Nervous System Diseases | - | - |
Vasovist (BAY86-5283, MS-325) | Phase 3 | Peripheral Vascular Diseases | - | - |
Moxifloxacin (Avelox, BAY12-8039) | Phase 3 | Abscess | - | - |
Rogaratinib (BAY1163877) | Phase 3 | Carcinoma, Transitional Cell | - | - |
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) | Phase 2 | Malignant Melanoma | - | - |
Regorafenib (CT) | Phase 2 | Colorectal Cancer | - | - |
Larotrectinib monotherapy | Phase 2 | Differentiated Thyroid Cancer | - | - |
BAY 3670549 | Phase 2 | Atrial Fibrillation | - | - |
GM-CSF, sargramostim | Phase 2 | Ovarian Cancer | - | - |
GM-CSF (Sargramostim) | Phase 2 | Leukemia | - | - |
Darbepoetin | Phase 2 | Anemia | - | - |
Naproxen gel | Phase 2 | Soft Tissue Injury | - | - |
Amikacin (BAY41-6551) | Phase 2 | Pneumonia | - | - |
BAY94-8862 | Phase 2 | Diabetic Nephropathies | - | - |
RDEA119 | Phase 2 | Advanced Cancer | - | - |
Vilaprisan (BAY1002670) | Phase 2 | Leiomyoma | - | - |
Gadobutrol~0.03 mmol/kg BW (Gadavist, Gadovist, BAY86-4875) | Phase 2 | Brain Diseases | - | - |
Taxane (Cytotoxic, BAY59-8862) | Phase 2 | Lymphoma, Non-Hodgkin | - | - |
Naproxen sodium/Caffeine (BAY2880376) | Phase 2 | Pain, Postoperative | - | - |
Molidustat (BAY 85-3934) | Phase 2 | Anemia | - | - |
Drospirenone/17ß-estradiol (Angeliq, BAY86-4891) | Phase 2 | Postmenopause | - | - |
BAY2927088_formulation A | Phase 2 | Advanced Non-small Cell Lung Cancer | - | - |
BAY3427080 | Phase 2 | Post-menopausal Vasomotor Symptoms | - | - |
SH T04769G | Phase 2 | Oral Contraceptive | - | - |
Sagopilone (ZK 219477) + prednisone | Phase 2 | Prostate Cancer | - | - |
Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin | Phase 2 | Carcinoma, Hepatocellular | - | - |
BAY86-9766 MEK Inhibitor + Sorafenib | Phase 2 | Carcinoma, Hepatocellular | - | - |
BAY86-9766+Gemcitabine | Phase 2 | Pancreatic Neoplasms | - | - |
BAY1902607 | Phase 2 | Cough | - | - |
STW5 (Iberogast®, BAY98-7411) | Phase 2 | Functional Gastrointestinal Disorders | - | - |
BAY1067197 (10 mg) | Phase 2 | Heart Failure | - | - |
Zabedosertib (BAY1834845) | Phase 2 | Atopic Dermatitis | - | - |
Piroxicam ( BAYl1902) | Phase 2 | Contraception, Postcoital | - | - |
ZK245186 | Phase 2 | Atopic Dermatitis | - | - |
Sorafenib (Nexavar, BAY43-9006) + mFOLFOX6 (5-FU, levo-leucovorin, oxaliplatin) | Phase 2 | Metastatic Colorectal Cancer | - | - |
Nifurtimox | Phase 2 | Neuroblastoma | - | - |
Pneumococcal Vaccine | Phase 2 | Leukemia | - | - |
BAY3018250 | Phase 2 | Thrombolysis | - | - |
BAY2433334 | Phase 2 | Atrial Fibrillation (AF) | - | - |
VVD-133214 | Phase 2 | Colorectal Adenocarcinoma | - | - |
Histone Deacetylase Inhibitor, MS-275 (BAY 86-5274, ZK 244894) | Phase 2 | Melanoma | - | - |
Fulacimstat (BAY1142524) | Phase 2 | Myocardial Infarction | - | - |
BAY1193397 | Phase 2 | Diabetic Foot | - | - |
BAY2586116 (A1) | Phase 2 | Sleep Apnea, Obstructive | - | - |
Levonorgestrel IUS (BAY86-5028, G04209B) | Phase 2 | Contraception | - | - |
BAY59-8862 (Cytotoxic Taxane) | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
Dehydroepiandrosterone, BAY86-5314 | Phase 2 | Libido | - | - |
BAY1213790 (Osocimab) | Phase 2 | End-stage Renal Disease | - | - |
Dexpanthenol foam spray, old formulation | Phase 2 | Erythema | - | - |
BAY2253651 | Phase 2 | Sleep Apnea, Obstructive | - | - |
Hydrocortison cream | Phase 2 | Atopic Dermatitis | - | - |
BAY60-4552 plus Vardenafil | Phase 2 | Erectile Dysfunction | - | - |
Mapracorat | Phase 2 | Atopic Dermatitis | - | - |
Darolutamide(BAY1841788, Nubeqa) | Phase 2 | Biochemically Recurrent Prostate Cancer | - | - |
Vardenafil HCl (Levitra, BAY38-9456) | Phase 2 | Overactive Bladder | - | - |
Ethinylestradiol/Gestogene (BAY86-5016) | Phase 2 | Contraception | - | - |
Sagopilone (ZK 219477) + carboplatin | Phase 2 | Ovarian Neoplasms | - | - |
BAY73-4506 (Regorafenib, Stivarga) | Phase 2 | Solid Cancer | - | - |
BAY1817080 | Phase 2 | Overactive Bladder | - | - |
EV/DNG (SH T00658L) | Phase 2 | Ovulation Inhibition | - | - |
BAY2757556 (Larotrectinib, Vitrakvi) | Phase 2 | Solid Tumors Harboring NTRK Fusion | - | - |
Vericiguat (BAY1021189) (1.25 mg) | Phase 2 | Heart Failure | - | - |
BAY73-4506 | Phase 2 | Carcinoma, Hepatocellular | - | - |
ZK 245186 | Phase 2 | Atopic Dermatitis | - | - |
Active comparator | Phase 2 | Venous Thrombosis | - | - |
Refametinib (BAY86-9766) | Phase 2 | Carcinoma, Hepatocellular | - | - |
BAY1142524 | Phase 2 | Heart Failure | - | - |
Radium-223 chloride (BAY88-8223) | Phase 2 | Breast Cancer | - | - |
Interferon | Phase 2 | Carcinoma, Renal Cell | - | - |
Sagopilone 16 mg/m^2 i.v., Acetyl-L-Carnitine (ALC) 1000 mg tid, HRPC only: Prednisone or Prednisolone 5 mg bid | Phase 2 | Prostate Cancer | - | - |
Dexpanthenol foam spray, new formulation | Phase 2 | Skin Abnormalities | - | - |
PEG 3350 laxative plus electrolytes (PEG + E)/Macrogol (Movicol®, BAY81-8430) | Phase 2 | Constipation | - | - |
Betaseron (Interferon beta-1b, BAY86-5046) | Phase 2 | Multiple Sclerosis | - | - |
BAY85-3934 | Phase 2 | Anemia | - | - |
Zevalin (SH L 749 , BAY86-5128) | Phase 2 | Non-Hodgkin's Lymphoma | - | - |
Cladribine | Phase 2 | Acute Biphenotypic Leukemia | - | - |
Enoxaparin/Vitamin K-Antagonist | Phase 2 | Venous Thrombosis | - | - |
BAY86-4891 (Estradiol / Drospirenone) | Phase 2 | Contraception | - | - |
Runcaciguat (BAY1101042) | Phase 2 | Diabetic Retinopathy | - | - |
Yasminelle (SH T 00186 D) | Phase 2 | Contraceptives, Oral | - | - |
Gadobutrol (Gadavist,Gadovist, BAY86-4875) | Phase 2 | Myocardial Perfusion Imaging | - | - |
BAY 1753011 | Phase 2 | Heart Failure (HF) | - | - |
BAY2586116 | Phase 2 | Sleep Apnea, Obstructive | - | - |
Sagopilone (BAY86-5302, ZK 219477) | Phase 2 | Breast Neoplasms | - | - |
Combination drug | Phase 2 | Cancer | - | - |
BAY85-8501 | Phase 2 | Bronchiectasis | - | - |
Eplerenone | Phase 2 | Heart Failure | - | - |
BAY3283142 | Phase 2 | Chronic Kidney Disease | - | - |
Larotrectinib (Vitrakvi, BAY2757556) | Phase 2 | Solid Tumors Harboring NTRK Fusion | - | - |
Sorafenib (BAY43-9006) | Phase 2 | Carcinoma, Hepatocellular | - | - |
Magnevist (Gadopentetate dimeglumine, BAY86-4882) | Phase 2 | Myocardial Infarction | - | - |
Gadobutrol (Gadovist/Gadavist) | Phase 2 | Central Nervous System Pathology | - | - |
Interferon beta 1b (Betaseron, BAY86-5046) | Phase 2 | Multiple Sclerosis, Relapsing-Remitting | - | - |
Capadenoson (BAY68-4986) | Phase 2 | Atrial Fibrillation | - | - |
Xarelto (Rivaroxaban, BAY59-7939) | Phase 2 | Atrial Fibrillation | - | - |
CCR1-Antagonist (BAY86-5047, ZK811752) | Phase 2 | Endometriosis | - | - |
Afatinib | Phase 2 | Non-small Cell Lung Carcinoma | - | - |
Sorafenib (Nexavar,BAY43-9006) | Phase 2 | Thyroid Carcinoma | - | - |
BAY98-7443 | Phase 2 | Contraception | - | - |
Fesomersen sodium (BAY2976217) | Phase 2 | End Stage Renal Disease Requiring Hemodialysis | - | - |
Sorafenib (Nexavar, BAY43-9006) + Dacarbazine (DTIC) | Phase 2 | Melanoma | - | - |
Nivolumab (Opdivo) | Phase 2 | Colorectal Cancer | - | - |
lloprost(Ventavis,BAYQ6252, 20 µg/mL) | Phase 2 | Pulmonary Arterial Hypertension | - | - |
Inspra (eplerenone) | Phase 2 | Heart Failure | - | - |
BAY 77-1931 | Phase 2 | Hyperphosphatemia | - | - |
Anetumab ravtansine (BAY94-9343) | Phase 2 | Mesothelioma | - | - |
BAY1067197 (treatment 2) | Phase 2 | Heart Failure | - | - |
BAY2395840 | Phase 2 | Neuropathic Pain Associated With Diabetic Peripheral Neuropathy | - | - |
Levonorgestrel | Phase 2 | Endometriosis | - | - |
Copanlisib (BAY80-6946) | Phase 2 | Lymphoma Non-Hodgkin | - | - |
Bay 59-8862 | Phase 2 | Carcinoma, Renal Cell | - | - |
BAY2599023 (DTX201) | Phase 2 | Hemophilia A | - | - |
runcaciguat | Phase 2 | Chronic Kidney Disease | - | - |
E2/DRSP (BAY 86-4891) dose 1 (SH T04984E) | Phase 2 | Contraceptive, Oral, Hormonal | - | - |
Repinotan HCl (BAYX3702) | Phase 2 | Stroke | - | - |
Neladenoson bialanate (BAY1067197) | Phase 2 | Heart Failure | - | - |
SH T00268C | Phase 2 | Non Small Cell Lung Cancer | - | - |
Polyethylene Glycol (PEG 3350) | Phase 2 | Constipation | - | - |
Finerenone (BAY94-8862 ) 10 mg | Phase 2 | Type 2 Diabetes Mellitus | - | - |
Bifonazole spray once daily | Phase 2 | Tinea Pedis | - | - |
Elinzanetant | Phase 2 | Sleep Disturbances Associated With Menopause | - | - |
Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A) | Phase 2 | Magnetic Resonance Angiography | - | - |
AAV2-GDNF gene therapy | Phase 2 | Parkinson Disease | - | - |
OpCT-001 | Phase 2 | Primary Photoreceptor Disease | - | - |
Naproxen Sodium (Aleve, BAY117031) | Phase 2 | Osteoarthritis, Knee | - | - |
BAY 3713372 | Phase 2 | MTAP-deleted Solid Tumors | - | - |
(LMW) Heparin + Vitamin K Antagonist | Phase 2 | Venous Thromboembolism | - | - |
Rivaroxaban, (BAY59-7939) | Phase 2 | Venous Thromboembolism | - | - |
Sorafenib (BAY 43-9006) | Phase 2 | Malignant Melanoma | - | - |
Interleukin-2 SA | Phase 2 | HIV Infections | - | - |
Candesartan cilexetil (Atacand), 4 mg | Phase 2 | Hypertension, Essential | - | - |
BAY 3401016 | Phase 2 | Alport Syndrome | - | - |
anetumab ravtansine | Phase 2 | Pancreatic Cancer | - | - |
Vericiguat (BAY1021189) 2.5 mg, 5 mg or 10 mg IR tablets | Phase 2 | Chronic Heart Failure With Preserved Ejection Fraction | - | - |
Epoetin alfa/beta | Phase 2 | Anemia | - | - |
Asoprisnil (BAY86-5294) | Phase 2 | Menorrhagia | - | - |
Vericiguat (BAY1021189) | Phase 2 | Calcific Aortic Valve Disease | - | - |
BAY1002670 | Phase 2 | Leiomyoma | - | - |
Lonaprisan (ZK 230211, BAY86-5044) | Phase 2 | Metastatic Breast Cancer | - | - |
Sagopilone (BAY86-5302 , ZK219477) | Phase 2 | Ovarian Neoplasms | - | - |
Vericiguat (BAY1021189) (5 mg) | Phase 2 | Heart Failure | - | - |
Phenylephrine HCl | Phase 2 | Rhinitis | - | - |
Oxymetazoline HCl 0.05% nasal gel | Phase 2 | Nasal Congestion | - | - |
Regorafenib, (Stivarga, BAY73-4506) | Phase 2 | Solid Tumors | - | - |
Sagopilone (ZK 219477) | Phase 2 | Breast Neoplasm | - | - |
Nifedipine (Adalat CR, BAYA1040) 80mg OD | Phase 2 | Hypertension | - | - |
UFH | Phase 2 | Cardiovascular Disease | - | - |
Vericiguat (BAY1021189) 5 mg | Phase 2 | Chronic Heart Failure With Reduced Ejection Fraction | - | - |
BAY 86-5310 (ZK 283197) | Phase 2 | Vasomotor System | - | - |
Copanlisib | Phase 2 | Marginal Zone Lymphoma | - | - |
Radium-223 | Phase 2 | Prostate Cancer | - | - |
sorafenib tosylate | Phase 2 | Adult Primary Hepatocellular Carcinoma | - | - |
Riociguat (Adempas, BAY63-2521). | Phase 2 | Hypertension, Pulmonary | - | - |
chemotherapy followed by Zevalin | Phase 2 | Diffuse Large B-cell Lymphoma | - | - |
Vericiguat Oral Tablet | Phase 2 | Post-COVID ME/CFS | - | - |
Nexavar (Sorafenib) | Phase 2 | Breast Cancer | - | - |
Adempas | Phase 2 | Chronic Thromboembolic Disease (CTED) | - | - |
Sorafenib and Gemcitabine | Phase 2 | Carcinoma, Hepatocellular | - | - |
Rivaroxaban 10 MG Oral Tablet [Xarelto] | Phase 2 | Bariatric Surgery | - | - |
Darolutamide 600 mg twice daily | Phase 2 | Prostate Cancer | - | - |
SH D01155E | Phase 2 | Pregnancy, Unplanned | - | - |
Abiraterone acetate | Phase 2 | Prostate Cancer | - | - |
Etoposide | Phase 2 | Lymphoma | - | - |
Riociguat | Phase 2 | Scleroderma | - | - |
Regorafenib (BAY 73-4506) | Phase 2 | Colorectal Cancer Metastatic | - | - |
Technetium Tc 99M Medronate | Phase 2 | Castration-Resistant Prostate Carcinoma | - | - |
Capecitabine/Cisplatin + Sorafenib | Phase 2 | Malignant Neoplasm of Stomach | - | - |
Interferon-α-2b | Phase 2 | Leukemia | - | - |
CHOP regimen alternate with ESHAP regimen | Phase 2 | Peripheral T-cell Lymphoma | - | - |
Campath-1H | Phase 2 | Lymphoplasmacytic Lymphoma | - | - |
Epirubicin Hydrochloride | Phase 2 | Pleomorphic Rhabdomyosarcoma | - | - |
Concurrent use of Radium Ra 223 dichloride and Abiraterone Acetate plus Prednisone | Phase 2 | Prostate Cancer | - | - |
Non-active base from azelaic acid 15% gel | Phase 2 | Perioral Dermatitis | - | - |
emodepside | Phase 2 | Onchocerciasis | - | - |
Ciprofloxacin (Cipro Inhale, BAYQ3939) | Phase 2 | Cystic Fibrosis | - | - |
Sargramostim (GM-CSF) | Phase 2 | Lymphoma | - | - |
sorafenib, vorinostat and bortezomib | Phase 2 | Acute Myeloid Leukemia | - | - |
CS1001 | Phase 2 | Advanced Refractory Solid Tumors | - | - |
ZK-EPO | Phase 2 | Melanoma | - | - |
Spironolactone | Phase 2 | Heart Failure | - | - |
Sorafenib Plus Capecitabine (SorCape) | Phase 2 | Colorectal Cancer Metastatic | - | - |
Ra-223 Dichloride | Phase 2 | Sarcoma | - | - |
Ara-C | Phase 2 | AML | - | - |
Sargramostim | Phase 2 | Chronic Lymphocytic Leukemia | - | - |
Peri-operative darolutamide + surgery. | Phase 2 | Prostate Cancer | - | - |
BAY1213790 | Phase 2 | Knee Arthroplasty, Total | - | - |
Isoniazid | Phase 2 | Tuberculosis | - | - |
FOLFOX chemotherapy with oxaliplatin | Phase 2 | Esophagogastric Cancer | - | - |
Radium Ra 223 Dichloride | Phase 2 | Prostate Cancer Metastatic to Bone | - | - |
Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF | Phase 2 | AML | - | - |
Sorafenib, administered orally | Phase 2 | Esophageal Cancer | - | - |
Finerenone Oral Tablet | Phase 2 | Kidney Transplant; Complications | - | - |
Azacytidine | Phase 2 | Leukemia | - | - |
CAMPTH-1H | Phase 2 | Non-Hodgkins Lymphoma | - | - |
CapeOX | Phase 2 | Gastric Adenocarcinoma | - | - |
ISIS 416858 | Phase 2 | End-stage Renal Disease (ESRD) | - | - |
Moxifloxacin (with rifampin, pyrazinamide, and ethambutol) | Phase 2 | Tuberculosis | - | - |
Ibritumomab Tiuxetan (Zevalin) | Phase 2 | Diffuse Large B-Cell Lymphoma | - | - |
Vericiguat | Phase 2 | Vasospastic Angina | - | - |
testosterone undecanoate | Phase 2 | Nonalcoholic Steatohepatitis | - | - |
Association of darolutamide and EBRT | Phase 2 | Prostate Cancer | - | - |
Sorafenib and Temozolomide | Phase 2 | Recurrent Glioblastoma Multiforme | - | - |
Azelaic acid foam 15% | Phase 2 | Papulopustular Rosacea | - | - |
Radium-223 dichloride | Phase 2 | Prostate Cancer | - | - |
Hormone Therapy | Phase 2 | Breast Cancer | - | - |
Perindopril | Phase 2 | Metastatic Colorectal Cancer | - | - |
Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection | Phase 2 | Multiple Sclerosis, Relapsing-Remitting | - | - |
ZBEAM (Zevalin, BCNU, Etoposide, Aracytine, Melphalan) | Phase 2 | Lymphoma, Large Cell, Diffuse | - | - |
90Y Ibritumomab tiuxetan | Phase 2 | Follicular Lymphoma | - | - |
Testosterone cypionate | Phase 2 | Metastatic Castration-resistant Prostate Cancer | - | - |
mycophenolate or cyclosporine and methotrexate | Phase 2 | Graft Versus Host Disease | - | - |
R-CHOP Chemotherapy | Phase 2 | Diffuse Large B Cell Lymphoma | - | - |
Contraception
3 drugs in this indication
Leukemia
1 drug in this indication
Diffuse Large B Cell Lymphoma
1 drug in this indication
chronic heart failure with preserved or mildly reduced ejection fraction
1 drug in this indication
Differentiated Thyroid Cancer
1 drug in this indication
Atrial Fibrillation
1 drug in this indication
Chronic Kidney Disease (CKD) and Type 1 Diabetes
1 drug in this indication
Parkinsons Disease (PD)
1 drug in this indication
Chronic kidney disease associated with Type 1 diabetes
1 drug in this indication
Chronic Kidney Disease (CKD) and Type 1 Diabetes in adults
1 drug in this indication
Crop protection and yield optimization
1 drug in this indication
HER2-mutant non-small cell lung cancer, first-line
1 drug in this indication
first-line targeted therapy for patients with HER2-mutated non-small cell lung cancer
1 drug in this indication
First-line treatment for adults with HER2-mutant non-small cell lung cancer
1 drug in this indication
Ovarian Cancer
1 drug in this indication
kidney disease
1 drug in this indication
Colorectal Cancer
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in BAYER's drug pipeline?→
CatalystAlert tracks 446 drug candidates in BAYER's (BAYRY) pipeline across Phase 3, Phase 2. Its lead program is BAY86-5016, SH P00331F (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is BAYER's next FDA catalyst?→
BAYER's (BAYRY) next tracked catalyst is a Phase 2 expected September 18, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track BAYRY biotech catalysts?→
Add BAYRY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow BAYER's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.